List view / Grid view
5 July 2016 | By Victoria White, Digital Content Producer
The six-month study will enrol 60 to 120 Ebola survivors whose semen has evidence of Ebola virus RNA prior to their enrolment...
20 April 2016 | By Victoria White, Digital Content Producer
Data from a Phase I study of a preventive Ebola vaccine regimen suggest that the regimen was well-tolerated by healthy volunteers and immunogenic...
30 March 2016 | By Victoria White
Inovio’s Ebola vaccine, INO-4212, was safe, tolerable, and generated strong T cell and antibody responses in its Phase I study of 75 healthy subjects...
22 October 2015 | By Victoria White
GS-5734 was discovered as part of Gilead’s programme to screen compounds in its libraries for activity against a range of potential emerging viruses, including Ebola...
15 September 2015 | By Victoria White
Crucell Holland has been awarded $28.5 million from BARDA to help accelerate the development of its investigational Ebola prime-boost vaccine regimen...
17 August 2015 | By Victoria White
An epidemiological week has now passed with no new Ebola cases in Sierra Leone for the first time since the beginning of the outbreak...
31 July 2015 | By Victoria White
Merck said today that its Ebola vaccine candidate, rVSV-ZEBOV, was found to have 100% efficacy in an analysis of interim data from a Phase 3 ring trial...
22 July 2015 | By Victoria White
Novavax has announced positive top-line data from a Phase 1 clinical trial of its Ebola virus glycoprotein recombinant nanoparticle vaccine candidate...
21 July 2015 | By Victoria White
Tekmira Pharmaceuticals Corporation has announced plans to change its corporate name to Arbutus Biopharma Corporation, to be effective by 3 August 2015...
15 July 2015 | By Victoria White
Oxford Vaccine Group has initiated a Phase 2 clinical study of the Ebola prime-boost vaccine regimen that combines MVA-BN-Filo with Ad26.ZEBOV...
23 June 2015 | By Victoria White
Tekmira has announced that the Phase II clinical trial of TKM-Ebola-Guinea has reached a predefined statistical endpoint and enrollment has been closed.
13 May 2015 | By Victoria White
EIB has reaffirmed its commitment to respond to the Ebola pandemic by providing a EUR 50m loan to Bavarian Nordic for accelerated development of a vaccine...
12 May 2015 | By Victoria White
Inovio Pharmaceuticals has initiated a Phase I trial to evaluate safety, tolerability and immune responses of its Ebola DNA immunotherapy...
11 May 2015 | By Victoria White
WHO has declared Liberia free of Ebola transmission - forty-two days have passed since the last laboratory-confirmed case was buried...
13 April 2015 | By Victoria White
The FDA has modified the partial clinical hold on the IND for TKM-Ebola to permit repeat dosing of healthy volunteers at a dose of 0.24 mg/kg/day...
